Lenvatinib Mesylate and Paclitaxel protein-bound Intravenous
Determining the interaction of Lenvatinib Mesylate and Paclitaxel protein-bound Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: paclitaxel protein-bound
Brand name: Abraxane
Synonyms: Paclitaxel protein-bound, PACLitaxel (Protein Bound)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Pacnex
- Lenvatinib Mesylate-Pacnex LP
- Lenvatinib Mesylate-Pacnex MX
- Lenvatinib Mesylate-Pain Enz Topical
- Lenvatinib Mesylate-Pain Relief PM Extra Strength
- Lenvatinib Mesylate-Pain Reliever Plus
- Paclitaxel protein-bound Intravenous-Lenvima
- Paclitaxel protein-bound Intravenous-Lenvima (14 MG Daily Dose)
- Paclitaxel protein-bound Intravenous-Lenvima (18 MG Daily Dose)
- Paclitaxel protein-bound Intravenous-Lenvima (20 MG Daily Dose)
- Paclitaxel protein-bound Intravenous-Lenvima (24 MG Daily Dose)
- Paclitaxel protein-bound Intravenous-Lenvima (8 MG Daily Dose)